Display Settings:

Format

Send to:

Choose Destination
    Br J Cancer. 2003 Mar 24;88(6):803-7.

    Nonsteroidal anti-inflammatory drugs in colorectal cancer: from prevention to therapy.

    Source

    Dipartimento di Biologia e Patologia Cellulare e Molecolare 'L. Califano', Istituto di Endocrinologia ed Oncologia Sperimentale 'G. Salvatore' del Consiglio Nazionale delle Ricerche, Università Federico II, via S. Pansini 5, Napoli 80131, Italy.

    Abstract

    In this review, we discuss the available experimental evidences supporting the chemopreventive efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) on colorectal cancer and the biological basis for their possible role as anticancer agents. Although the comprehension of the mechanisms underlying the effects of these drugs on colon cancer cells is incomplete, research efforts in identifying the biochemical pathway by which NSAIDs exert their chemopreventive effect have provided a rationale for the potential use of NSAIDs alone or in combination with conventional and experimental anticancer agents in the treatment of colorectal cancer. In this paper, we review three main issues: (i) the role of COX-2 in colon cancer; (ii) the common death pathways between NSAIDs and anticancer drugs; and (iii) the biological basis for the combination therapy with COX-2 selective inhibitors and new selective inhibitors of growth factor signal transduction pathways.

    PMID:
    12644813
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2377068
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Nature Publishing Group Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk